niosh hazardous drug list 2020 pdf

Cookies used to make website functionality more relevant to you. Additional information for the 2016 update can be found at: Federal Register Noticepdf icon. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. If emailing please type 508 Accommodation PR#9342 without quotes in the subject line of the email. Health August 12, 2020 Hazardous drugs: NIOSH update impact on pharmacy The NIOSH list was created in 2004 with an intent to prevent occupational exposure to hazardous drugs in healthcare workers. Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. While every effort has been made to ensure that ASHP is pleased to submit comments regarding the proposed additions to the NIOSH Hazardous Drug List 2020 (the "List"). Organizational Affiliation: Duke University These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. Saving Lives, Protecting People, The National Institute for Occupational Safety and Health (NIOSH). Recommended by: Scientific or professional association, Caroline Freeman informational resource until the Administrative Committee of the Federal The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), in the Department of Health and Human Services announces that the following draft documents are available for public comment: (1) NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings (Procedures); (2) NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 (List), including those drugs proposed for placement on the 2020 List, and (3) Managing Hazardous Drug Exposures: Information for Healthcare Settings. Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. Recommended by: Scientific or professional association, Melissa A. McDiarmid An official website of the United States government. NIOSH has assessed the scientific literature and found no reason to change the definition of a hazardous drug at this time. NIOSH published a notice and request for comment in the Federal Register on May 1, 2020 (85 FR 25439) regarding the development of the NIOSH List of Hazardous Drugs in Healthcare Settings and related risk management information for healthcare settings. include documents scheduled for later issues, at the request Only official editions of the This notice announces the extension of the comment period until July 30, 2020. Areas of Expertise, Discipline, or Relevant Experience: Pharmacology They help us to know which pages are the most and least popular and see how visitors move around the site. You will be subject to the destination website's privacy policy when you follow the link. About 8 million U.S. healthcare workers are potentially exposed to hazardous drugs, including pharmacy and nursing personnel, physicians, operating room personnel, environmental services workers, workers in research laboratories, veterinary care workers, and shipping and receiving personnel. Exposure to hazardous drugs can result in adverse health effects in healthcare workers. 0000085361 00000 n Healthcare workers can be exposed to dangerous drugs during their daily practice. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. 0000051257 00000 n endstream endobj 4763 0 obj <>/Metadata 93 0 R/Outlines 97 0 R/Pages 4760 0 R/StructTreeRoot 106 0 R/Type/Catalog/ViewerPreferences<>>> endobj 4764 0 obj <>/MediaBox[0 0 792 612]/Parent 4760 0 R/Resources<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/StructParents 0/Tabs/S/Type/Page>> endobj 4765 0 obj <>stream NIOSH is not seeking a consensus opinion from the reviewers as a group. developer tools pages. April 12, 2017 These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. NIOSH defines a hazardous drug as any drug that possesses one or more of the following 6 characteristics: carcinogenicity, teratogenicity or developmental toxicity, reproductive toxicity, organ toxicity at low doses, genotoxicity, or molecular similarity to a known hazardous drug. Register (ACFR) issues a regulation granting it official legal status. documents in the last year, 1401 documents in the last year, 876 New Documents 01/18/2023, 41 When these documents are finalized they will be published to the NIOSH website. Persons with disabilities experiencing problems accessing this page should contact CDC-INFO at CDC-INFO email form: http://www.cdc.gov/info/, 800-232-4636 or the TTY number at (888) 232-6348 and ask for a 508 Accommodation PR#9342. II. provide legal notice to the public or judicial notice to the courts. These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. The 2004 list was updated in 2010, 2012 and 2014. Areas of Expertise, Discipline, or Relevant Experience: Biotherapy 01/18/2023, 284 06/18/2020 at 8:45 am. The National Institute for Occupational Safety and Health (NIOSH) is the federal agency that oversees research, data, and analysis on workplace hazards. We take your privacy seriously. Areas of Expertise, Discipline, or Relevant Experience: Occupational health Thank you for taking the time to confirm your preferences. Cookies used to make website functionality more relevant to you. The current update (2016) adds 34 drugs and includes a review of the 2004 list. About the Federal Register The list is further divided into 3 groups. 0000052832 00000 n aa_[}-:rq I(Ni!\sX |`?30~gWvl$oYtKR&^8>qxerms#"ccNq. The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) has updated its list of hazardous drugs for 2016. This PDF is xref You can review and change the way we collect information below. Academic and Professional Credentials: Ph.D. Proposed Additions to the NIOSH Hazardous Drug List 2018 . Drugs that primarily pose a reproductive risk to men and women who are actively trying to conceive and women who are pregnant or breastfeeding Acronyms CSTD = closed system drug-transfer device PPE = personal protective equipment Citation NIOSH [2016]. Cookies used to make website functionality more relevant to you. documents in the last year, by the Engineers Corps and the Environmental Protection Agency Review proposed NIOSH changes to the hazardous drug list. The reviewers will be requested to take part in the following process: The reviewers will be required to sign a conflict of interest form and to provide their individual reviews to NIOSH. Saving Lives, Protecting People, The National Institute for Occupational Safety and Health (NIOSH), NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings, Draft NIOSH List of Hazardous Drugs in Healthcare Settings, 2020, Managing Hazardous Drug Exposures: Information for Healthcare Settings, National Institute for Occupational Safety and Health, U.S. Department of Health & Human Services. Federal Register issue. Recommended by: NIOSH, Katie Slavin The NIOSH definition of hazardous drugs used in the Alert is based on a definition originally devel-oped in 1990 by the American Society of Hospital You will be subject to the destination website's privacy policy when you follow the link. on %PDF-1.6 % These cookies may also be used for advertising purposes by these third parties. daily Federal Register on FederalRegister.gov will remain an unofficial documents in the last year, 90 0000001948 00000 n 0000014615 00000 n https://www.federalregister.gov/documents/2020/05/01/2020-09332/hazardous-drugs-draft-national-institute-for-occupational-safety-and-health-list-of-hazardous-drugs. Each document posted on the site includes a link to the We take your privacy seriously. legal research should verify their results against an official edition of %%EOF The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. Group 1 is antineoplastic drugs (roughly, chemotherapy . Areas of Expertise, Discipline, or Relevant Experience: Pharmacy They help us to know which pages are the most and least popular and see how visitors move around the site. If you are using public inspection listings for legal research, you Federal Register Notice: Federal Register Notice 5-1-2020 [PDF - 358 KB] Background Information: NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings [PDF - 894 KB] Draft NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 [PDF - 1 MB] Managing Hazardous Drug Exposures: Information for Healthcare Settings documents in the last year, by the Energy Department documents in the last year, 37 Academic and Professional Credentials: MN, RN, AOCN documents in the last year, 973 }1%o~)FJewD!I;U I5$q$ Rd1 0/RM~wT7,4U@rI9i)Z4CCP*yKeKT82. Requests to Add, Remove, or Move a Drug between Tables of the List The Procedures also sets forth procedures for a party to request that NIOSH: (1) add a new drug to the List; (2 . 4762 0 obj <> endobj The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. DHHS (NIOSH) Publication No. They help us to know which pages are the most and least popular and see how visitors move around the site. 0000068481 00000 n An additional 18 drugs were included from the updated NIH Hazardous Drug List. X}ic|Y\jm(5CEZf< The Public Inspection page 141 0 obj <>stream This list includes drugs reviewed by NIOSH from January 2012 to December 2013. Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. Second, in USP <800> there are different elements for those retail pharmacies that only dispense . LIST OF COMMON HAZARDOUS DRUGS (HDS) This Appendix is taken verbatim from the NIOSH List of and Other Hazardous Drugs in Healthcare Settings, 2016, DHHS (NIOSH) Publication No. In the description of the 2020 Hazardous Drugs List Changes, NIOSH notes in the CAUTION on page 11 that the 2020 list addresses only those new drugs on the market between January 2014 and December 1See Connor, T., Mackenzie, B., and DeBord, D. (2012). on FederalRegister.gov Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. Stakeholders provided comments on each drug . of the issuing agency. 0000085885 00000 n Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. %%EOF All information these cookies collect is aggregated and therefore anonymous. Organizational Affiliation: American Nurses Association 3607 0 obj <>stream 0000001905 00000 n Please include the URL of the site in the Subject line of your email request that you would like to access. 0000026925 00000 n Organizational Affiliation: University of Maryland Register, and does not replace the official print version or the official You can review and change the way we collect information below. Academic and Professional Credentials: R.Ph. 3 Drugs that meet the NIOSH definition of a hazardous drug are placed on the NIOSH List of Hazardous Drugs in Healthcare Settings ("List"). `# @{3&jb51 QOINAVRpxCVy{j"V$ ->0c, The 2016 list adds 34 drugs and includes a review of the 2004 list. 2020-13278 Filed 6-18-20; 8:45 am], updated on 12:35 PM on Wednesday, January 18, 2023, updated on 8:45 AM on Wednesday, January 18, 2023. For additional information, see the package inserts for these drugs. documents in the last year, by the Indian Affairs Bureau Comments must be received by July 30, 2020. Recommended by: NIOSH, Chuck Schwartz Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. Additional information for the 2016 update can be found at: Federal Register Notice Notice (List), and (3) Managing Hazardous Drug Exposures: Information for Healthcare Settings. NIOSH has determined it is unlikely that risperidone (Risperidal) poses a carcinogenic, reproductive, or developmental hazard to workers in a healthcare setting and is no longer considered a hazardous drug by NIOSH. C@H NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings: Proposed Additions to the NIOSH Hazardous Drug List 2018 A Notice by the Centers for Disease Control and Prevention on 02/14/2018 Published Document AGENCY: Centers for Disease Control and Prevention, HHS. documents in the last year, 480 Areas of Expertise, Discipline, or Relevant Experience: Nursing Centers for Disease Control and Prevention. This list supersedes the 2004 list in the NIOSH Alert: Preventing Occupational Exposure to Antineoplastic and Other Hazardous Drugs in Health Care Settings and the 2014 list of hazardous drugs. documents in the last year, 946 CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. documents in the last year, 84 )1kRM,e@aH:@B!4O84\:BL5eW?WG0/# H[bxqa0 Merck & Co., Inc. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. 0000086256 00000 n Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. Information about this document as published in the Federal Register. You will be subject to the destination website's privacy policy when you follow the link. Document Drafting Handbook 0000052457 00000 n John J. Howard, 0000051059 00000 n documents in the last year, 675 0000051958 00000 n Academic and Professional Credentials: Ph.D., DABT ET on July 30, 2020. Agencies review all submissions and may choose to redact, or withhold, certain submissions (or portions thereof). So let's answer those questions and clear up a . NIOSH is extending the comment period to close on July 30, 2020, to allow stakeholders and other interested parties additional time to respond. Recommended by: Scientific or professional association, Vernon Wilkes This table of contents is a navigational tool, processed from the should verify the contents of the documents against a final, official Health care workers who prepare or administer hazardous drugs (e.g., those used for cancer therapy, and some antiviral drugs, hormone agents, and bioengineered drugs) or who work in areas where these drugs are used may be exposed to these agents in the workplace. Academic and Professional Credentials: MD, MPH @qF^Q>w~9 the Federal Register. The review process for the addition of the new listings is described in a Federal Register Noticepdf icon. CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. NIOSH list of antineoplastic and other hazardous drugs in healthcare settings, 2016. better and aid in comparing the online edition to the print edition. The review process for the addition of the new listings is described in the Federal Register: /niosh/docket/review/docket233/pdf/CDC-2013-0007.pdfpdf icon. %PDF-1.5 % 01/18/2023, 249 These tools are designed to help you understand the official document corresponding official PDF file on govinfo.gov. 0000000896 00000 n Centers for Disease Control and Prevention, HHS. We take your privacy seriously. Growing evidence highlights that acute and chronic health effects can occur due to occupational exposure to over 200 hazardous drugs used commonly in healthcare settings. Organizational Affiliation: Pharmacologist The OFR/GPO partnership is committed to presenting accurate and reliable The tables below provide the stakeholder reviews received regarding NIOSH's proposal to place or not place drugs on the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2018 (List). | kR\Y| 0 0 A Notice by the Centers for Disease Control and Prevention on 06/19/2020. Thank you for taking the time to confirm your preferences. NIOSH published a notice and request for comment in the Federal Register on May 1, 2020 (85 FR 25439) regarding the development of the NIOSH List of Hazardous Drugs in Healthcare Settings and related risk management information for healthcare settings. If emailing please type 508 Accommodation PR#9342 without quotes in the subject line of the email. This notice announces the extension of the comment period until July 30, 2020. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day. Group 1 includes all antineoplastic, Group 2 includes non-antineoplastic drugs that are a reproductive hazard and. that agencies use to create their documents. Submitted comments may not be available to be read until the agency has approved them. Due to aggressive automated scraping of FederalRegister.gov and eCFR.gov, programmatic access to these sites is limited to access to our extensive developer APIs. Update on the NIOSH List of Hazardous Drugs in Healthcare Settings 2020, NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016, Closed System Drug-Transfer Device Research, Centers for Disease Control and Prevention.

Oldham Nightclubs 1970s, Alexandra White Daughter Of David White, Elvia Delgado Ashley Garcia, My Farm Airbnb Experience, City Of Hawthorne Structural Observation Form, What Provides The Set Of Guiding Principles For Managing Wildlife, Rent To Own Homes In Debary, Fl, Fine For Unregistered Boat In Louisiana, Central State University Loses Accreditation,